Cai Y - Search Results

1

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.

Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, Duan J, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yu J, Yao S, Shen R, Wang Z, Wang J. Xu J, et al. Among authors: cai y, cai s. Cancer Cell. 2024 Sep 9;42(9):1598-1613.e4. doi: 10.1016/j.ccell.2024.08.013. Cancer Cell. 2024. PMID: 39255777 Free article.

2

X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas.

Cai YR, Diao XL, Wang SF, Zhang W, Zhang HT, Su Q. Cai YR, et al. Int J Oncol. 2007 Dec;31(6):1379-89. Int J Oncol. 2007. PMID: 17982665

3

Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients.

Lu B, Zhang H, Zhang T, Cai Y, Hu Y, Zheng H, Li B. Lu B, et al. Among authors: cai y. Thorac Cancer. 2016 Jul;7(4):486-94. doi: 10.1111/1759-7714.12359. Epub 2016 May 11. Thorac Cancer. 2016. PMID: 27385993 Free PMC article.

4

Well-differentiated fetal adenocarcinoma of the lung: clinicopathologic features of 45 cases in China.

Zhang TM, Lu BH, Cai YR, Gao Y, Zhang HM, Wang QH, Hu AM, Li BL. Zhang TM, et al. Among authors: cai yr. Int J Clin Exp Pathol. 2018 Mar 1;11(3):1587-1598. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938258 Free PMC article.

5

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression.

Cai Y, Wu H, Shi X, Dong Y, Chang X, Zhang L, Zhou L, Su D, Yang M. Cai Y, et al. BMC Cancer. 2020 Feb 24;20(1):148. doi: 10.1186/s12885-020-6631-z. BMC Cancer. 2020. PMID: 32093629 Free PMC article.

6

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors.

Nie W, Wang ZJ, Zhang K, Li B, Cai YR, Wen FC, Zhang D, Bai YZ, Zhang XY, Wang SY, Cheng L, Zhong H, Liu L, Wang J, Han BH. Nie W, et al. BMC Med. 2022 May 5;20(1):170. doi: 10.1186/s12916-022-02360-x. BMC Med. 2022. PMID: 35509036 Free PMC article.

7

Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.

Zhou J, Bao M, Gao G, Cai Y, Wu L, Lei L, Zhao J, Ji X, Huang Y, Su C. Zhou J, et al. Among authors: cai y. BMC Med. 2022 Jul 29;20(1):256. doi: 10.1186/s12916-022-02444-8. BMC Med. 2022. PMID: 35902848 Free PMC article.

8

bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer.

Fan Y, Liu Y, Wang L, Cai Y, Cao W, Sun W, Zou X, Li B, Zhang Z, Cai S, Chuai S, Han Y, Pan X, Huang D. Fan Y, et al. Among authors: cai y, cai s. EBioMedicine. 2023 May;91:104564. doi: 10.1016/j.ebiom.2023.104564. Epub 2023 Apr 23. EBioMedicine. 2023. PMID: 37094467 Free PMC article.

9

Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.

Zhong J, Fei K, Wu L, Li B, Wang Z, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yao S, Yu J, Cai SL, Cai Y, Xu J, Zhuang W, Luo X, Duan J, Wang J. Zhong J, et al. Among authors: cai y, cai sl. Signal Transduct Target Ther. 2024 Dec 24;9(1):369. doi: 10.1038/s41392-024-02087-6. Signal Transduct Target Ther. 2024. PMID: 39715755 Free PMC article. Clinical Trial.

10

Analysis of clinical characteristics and prognosis of patients with anaplastic lymphoma kinase-positive and surgically resected lung adenocarcinoma.

Tao H, Cai Y, Shi L, Tang J, Liu Z, Wang Z, Bai L, Liu Z. Tao H, et al. Among authors: cai y. Thorac Cancer. 2017 Jan;8(1):8-15. doi: 10.1111/1759-7714.12395. Epub 2016 Oct 24. Thorac Cancer. 2017. PMID: 27779369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,542 results

Search Page

Filters